Elmind Capital, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Elmind Capital, LP held in its portfolio 34 assets valued at $338,852,146 (i.e. $338.85M).

The most valuable assets in the portfolio included: COGENT BIOSCIENCES INC ($41.59M), SYNDAX PHARMACEUTICALS INC ($38.97M), and VIRIDIAN THERAPEUTICS INC ($26.72M).

The chart below shows the top 10 valuable assets, and the table below shows the top 34 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in Elmind Capital, LP Portfolio
COGENT BIOSCIENCES INC
SYNDAX PHARMACEUTICALS INC
VIRIDIAN THERAPEUTICS INC
VERA THERAPEUTICS INC
CELLDEX THERAPEUTICS INC NEW
CG ONCOLOGY INC
BIOCRYST PHARMACEUTICALS INC
VAXCYTE INC
BEAM THERAPEUTICS INC
PHARVARIS N V
Elmind Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
COGENT BIOSCIENCES INC 1170740 41584685 COM
SYNDAX PHARMACEUTICALS INC 1855000 38973550 COM
VIRIDIAN THERAPEUTICS INC 858631 26720597 COM
VERA THERAPEUTICS INC 482500 24433800 CL A
CELLDEX THERAPEUTICS INC NEW 865000 23493400 COM NEW
CG ONCOLOGY INC 492500 20448600 COM
BIOCRYST PHARMACEUTICALS INC 2150000 16770000 COM
VAXCYTE INC 291500 13449810 COM
BEAM THERAPEUTICS INC 476338 13204089 COM
PHARVARIS N V 475750 13202063 COM
KALVISTA PHARMACEUTICALS INC 801300 12940995 COM
DYNAVAX TECHNOLOGIES CORP 679900 10456862 COM NEW
TYRA BIOSCIENCES INC 350000 9201500 COM
NURIX THERAPEUTICS INC 460000 8726200 COM
WAVE LIFE SCIENCES LTD 447846 7613382 SHS
MBX BIOSCIENCES INC 211000 6654940 COM
KRYSTAL BIOTECH INC 22000 5423880 COM
UNITED THERAPEUTICS CORP DEL 11000 5359750 COM
BIOMARIN PHARMACEUTICAL INC 82000 4873260 COM
RELAY THERAPEUTICS INC 536946 4542563 COM
TRAVERE THERAPEUTICS INC 110000 4203100 COM
PROTAGONIST THERAPEUTICS INC 38000 3318920 COM
CULLINAN THERAPEUTICS INC 310000 3208500 COM
LIQUIDIA CORPORATION 90000 3104100 COM NEW
CYTOMX THERAPEUTICS INC 700000 2982000 COM
UROGEN PHARMA LTD 100000 2342000 COM
IMMUNOCORE HLDGS PLC 58248 2021788 ADS
DESIGN THERAPEUTICS INC 207900 1950102 COM
ENGENE HOLDINGS INC 210000 1896300 COM
ALECTOR INC 900000 1404000 COM
AMYLYX PHARMACEUTICALS INC 112000 1352960 COM
APELLIS PHARMACEUTICALS INC 50000 1256000 COM
SUPERNUS PHARMACEUTICALS INC 20000 994000 COM
EDGEWISE THERAPEUTICS INC 30000 744450 COM